Skip main navigation

Blood Pressure, Internal Carotid Artery Flow Parameters, and Age-Related White Matter Hyperintensities

Originally publishedhttps://doi.org/10.1161/HYPERTENSIONAHA.113.02735Hypertension. 2014;63:1011–1018

Abstract

White matter hyperintensities (WMH) are associated with hypertension. We examined interactions among blood pressure (BP), internal carotid artery (ICA) flow velocity parameters, and WMH. We obtained BP measurements from 694 community-dwelling subjects at mean ages 69.6 (±0.8) years and again at 72.6 (±0.7) years, plus brain MRI and ICA ultrasound at age 73±1 years. Diastolic and mean BP decreased and pulse pressure increased, but systolic BP did not change between 70 and 73 years. Multiple linear regression, corrected for vascular disease and risk factors, showed that WMH at the age of 73 years were associated with history of hypertension (β=0.13; P<0.001) and with BP at the age of 70 years (systolic β=0.08, mean β=0.09, diastolic β=0.08; all P<0.05); similar but attenuated associations were seen for BP at the age of 73 years. Lower diastolic BP and higher pulse pressure were associated with higher ICA pulsatility index at the age 73 years (diastolic BP age 70 years: standardized β=−0.24, P<0.001; pulse pressure age 70 years: β=0.19, P<0.001). WMH were associated with higher ICA pulsatility index (β=0.13; P=0.002) after adjusting for BP and correction for multiple testing. Therefore, falling diastolic BP and increased pulse pressure are associated with increased ICA pulsatility index, which in turn is associated with WMH. This suggests that hypertension and WMH may either associate indirectly because hypertension increases arterial stiffness that leads to WMH over time, or coassociate through advancing age and stiffer vessels, or both. Reducing vascular stiffness may reduce WMH progression and should be tested in randomized trials, in addition to testing antihypertensive therapy.

Introduction

White matter hyperintensities (WMH) are indicators of cerebral small vessel disease1 and are implicated in the pathogenesis of cognitive impairment, stroke, and dementia.2 WMH are associated with hypertension and increased risk of stroke,35 but the mechanism through which elevated blood pressure (BP) affects the brain is unclear. Advancing age is associated with loss of elasticity in the large arteries and muscular arterioles and increased arterial stiffness. Several risk factors, particularly hypertension, contribute to the stiffness.3,68 Arterial stiffening impairs the damping of the arterial waveform in large arteries and could lead to excessive transmission of BP pulsation to the brain.9,10 Increasing stiffness of the large central arteries is associated with WMH.812 One explanation for the association between arterial stiffness and WMH is that arterial stiffening exposes small vessels in the brain to high pulsatility, damaging the small vessel wall.79 Because this cyclic variation in BP is transmitted to the brain through the internal carotid arteries (ICA), an association among BP, ICA flow parameters, and WMH might be expected.5 Few studies have compared BP, ICA or middle cerebral artery (MCA) blood flow velocity, and WMH.9,13

Previous studies9,10 that investigated BP and ICA or MCA velocity parameters and WMH have focused on the pulse pressure component of BP and the pulsatility index component of the Doppler MCA or ICA waveform. However, pulse pressure is determined by diastolic BP (DBP) and systolic BP (SBP), and the relative contribution of these is a function of age: in young adults, both DBP and SBP increase, whereas in the elderly SBP increases whereas DBP reduces with age.14

Here, we investigated the association between BP measured longitudinally, ICA blood flow velocity parameters, and age-related WMH in a well-characterized large community-dwelling cohort of older adults with a narrow age-range. We hypothesized that because the ICAs are the main conduits of blood to the brain, that BP must exert its effects on the brain via the ICAs and, therefore, that we should find positive associations between BP and ICA velocity parameters, and in turn between ICA velocity parameters and WMH, if indeed there is a direct relationship between high BP and WMH at older ages.

Methods

Subjects

Study participants were members of the Lothian Birth Cohort 1936 (LBC1936).15 They were all born in 1936, most undertook the Scottish Mental Survey of 1947,15 and most were living in the Lothian (Edinburgh) area of Scotland when first recruited into the LBC1936 between 2004 and 2007. At mean age of 70 years (LBC1936 wave 1), 1091 participants undertook detailed medical and cognitive assessments.15 Three years later (wave 2), repeat medical and cognitive assessments were conducted (n=866); in addition, at wave 2 they underwent carotid Doppler ultrasound imaging and brain MRI (n=700, protocols detailed elsewhere).16

Subjects provided history of ischemic heart disease, diabetes mellitus, hypertension (diagnosed or on treatment), smoking (coded here as ever smoked previously or currently), hypercholesterolemia, peripheral vascular disease, clinically evident stroke, and any other circulatory disease, and we calculated body mass index.

Written informed consent was obtained from all participants under protocols approved by the Lothian (REC 07/MRE00/58) and Scottish Multicentre (MREC/01/0/56) Research Ethics Committees; all procedures were conducted according to institutional guidelines and the Declaration of Helsinki.

BP Measurements

BP measurements were taken from the brachial artery at waves 1 and 2 by trained research nurses in a Clinical Research Facility (http://www.wtcrf.ed.ac.uk) using an Omron 705IT monitor. Three readings of SBP and DBP were taken, sitting and standing. We calculated average SBP and DBP for the 3 sittings (or standings) and pulse pressure for each wave. Brachial pulse pressure closely reflects aortic pulse pressure—of 5 measures of arterial stiffness outside the head, brachial pulse pressure showed the strongest correlation with, and explained the largest proportion of variance in, intracranial arterial stiffness.5 We also calculated mean BP (Equation 1).

((1))

We calculated BP variability using methods proposed previously1719: SD, coefficient of variation (SD of successive measurements divided by their mean value), average real variability (average absolute difference between successive measurements), and successive variation (average squared difference between successive measurements), separately for SBP and DBP (Tables S1 and S2 in the online-only Data Supplement) and for each time point using the 3 sitting (or standing) BP measurements. Note that the availability of 3 BP measurements for variability computation limits the strength of the metrics.

Carotid Doppler Ultrasound Imaging

Carotid Doppler ultrasound imaging was performed at wave 2 on a Siemens Antares Premium Color Doppler scanner (Siemens AG, Erlangen, Germany) with 7.5 MHz variable frequency probe by experienced neurovascular ultrasonographers. Blood flow velocity readings were obtained, after ≥5-minute rest supine with head on pillow, from the left and right common, internal and external carotid arteries,20 including peak systolic and end diastolic blood flow velocities from all arteries and averaged the right and left velocities. We calculated ICA mean flow velocity, pulsatility index, and resistivity index using average values of left and right ICAs in Equations 2, 3, and 4 (ICA systolic velocity and ICA end diastolic velocity). We calculated mean velocity,20,21 rather than using the machine-derived time averaged mean, to avoid inaccurate machine calculations occurring secondary to signal drop out or artifact from the velocity waveform. ICA velocity parameters, including pulsatility and resistivity indices, closely reflect intracranial arterial velocity parameters.5 Measuring blood velocity parameters in the ICAs avoids the problem of (1) the ≥10% data loss because of acoustically dense skull and (2) incorrect MCA velocity calculations because of assumed angle of insonance that occur with transcranial Doppler ultrasound.

((2)) ((3)) ((4))

Magnetic Resonance Brain Imaging

We report the imaging findings according to the Standards for Reporting Vascular Changes in Neurodegeneration criteria.1 All brain MRI data were acquired at wave 2 on a 1.5T GE Signa Horizon HDx scanner (General Electric, Milwaukee, WI) with a self-shielding gradient set, maximum gradient strength 33 mT/m, and an 8-channel phased-array head coil. The image acquisition included the following: T1-weighted coronal, T2-weighted, T2*-weighted, and fluid attenuated inversion recovery sagittal whole brain scans.16 WMH were segmented and volumes were measured using a validated multispectral image processing tool, MCMxxxVI (www.sourceforge.net/projects/bric1936).22 Intracranial volume was measured using the Image Edit tool in the Analyze 9.0.16 WMH were visually rated by an experienced, neuroradiologist on the fluid attenuated inversion recovery and T2-weighted images using the Fazekas scale,23 with deep and periventricular WMH first scored separately (0–3) and then the scores combined to give a total score out of 6.

Statistical Analysis

All statistical analyses were performed using SPSS version 19 (SPSS Inc, Chicago, IL); all statistical tests being 2-tailed, and P<0.05 being considered significant. BP measures at waves 1 and 2 were compared using paired t tests, and health conditions at waves 1 and 2 were compared using Wilcoxon rank-sum test.

Associations between BP measures, ICA blood velocity measures, and WMH were investigated using multivariate linear regression models. The covariates that are known or proposed predictors of WMH, BP, or blood velocity parameters were included in the analysis: age in days at MRI, sex, body mass index, and self-reported history of ischemic heart disease, stroke, peripheral vascular disease, other circulatory disorders, diabetes mellitus, hypertension, smoking, and hypercholesterolemia. We modeled the association among BP, ICA blood velocity parameters, and WMH in stages, each individually and then all 3 elements together. We tested associations with and without history of hypertension included in the models (to avoid overfitting) because there was little difference in the results whether hypertension was included; we report the results without hypertension as a covariate. All relevant covariates were included in the models, and multiple testing was corrected for using the false-discovery rate. We tested both WMH volume and Fazekas score and whether the associations differed between hypertensive and nonhypertensive subjects using Pearson bivariate analysis. Because WMH were not normally distributed, in sensitivity analyses, we log transformed the WMH but found no difference in the models between the raw and transformed WMH. This was unsurprising because of our large sample size. In view of these and to simplify the interpretation of results, we report the results of the untransformed WMH.

Results

Subjects

Of the 700 subjects with brain MRI, 6 had incomplete data reducing the final sample to 694 (Table 1), mean ages 69.6±0.8 and 72.6±0.7 years for waves 1 and 2, respectively, with the same proportion of men (53%) at both waves. The proportions with vascular diagnoses increased significantly between waves 1 and 2: hypertension (37%–48.7%), ischemic heart disease (21.7%–27.3%), diabetes mellitus (6.6%–11.0%), stroke (4.4%–6.9%), hypercholesterolemia (33.3%–41.4%), peripheral vascular disease (37.5%–42.1%), and other circulatory problems (13.6%–17.6%; all P<0.00). There was no significant difference in body mass index between waves 1 and 2. ICA stenosis >50% was only present (on either side) in 2.9%, and internal carotid occlusion on either side in 1 patient each (0.3%).

Table 1. Descriptive Statistics for Measures of BP, Blood Velocity in the ICA, WMH Measures, Demographic, and Health Conditions

Parameter Assessed Measures Mean (SD)
Wave 1 (n=1091) Wave 2 (n=694)
BP measures Peak systolic BP, mm Hg 149.45 (18.96) 148.69 (18.95)
Mean BP, mm Hg 104.00 (11.81) 102.00 (11.27)*
End diastolic BP, mm Hg 81.45 (10.17) 78.1 (9.68)*
Pulse pressure, mm Hg 68.00 (14.91) 71.34 (18.94)*
Measures of blood velocity in the ICA Peak systolic velocity, cm/s 59.91 (20.33)
Mean velocity, cm/s 32.53 (10.59)
End diastolic velocity, cm/s 18.85 (7.09)
Pulsatility index 1.27 (0.26)
Resistivity index 0.66 (0.40)
WMH and related measures White matter hyperintensities volume, cm3 12.05 (12.84)
Intracranial volume, cm3 1450.97 (140.57)
Percentage of white matter lesions in ICV 0.83 (0.90)
Total Fazekas scores, median (IQR) 2.00 (1.00)
Deep Fazekas scores, median (IQR) 1.00 (0)
Periventricular Fazekas scores, median (IQR) 1.00 (1)
Demographic and health conditions % Men 53 53
Age in years, mean (SD) 69.57 (0.83) 72.55 (0.71)
Body mass index, mean (SD) 27.83 (4.38) 27.98 (4.50)
History of hypertension, % 37.10 48.70
History of ischemic heart disease, % 21.70 27.30
History of diabetes mellitus, % 8.60 11.00
History of stroke, % 4.40 6.90
History of smoking, % 56.10
History of hypercholesterolemia, % 33.30 41.40
History of peripheral vascular diseases, % 37.50 42.10*
Problems with blood circulation, % 13.60 17.60*

Measures changed significantly from wave 1 to 2. BP indicates blood pressure; ICA, internal carotid artery; ICV, intracranial volume; IQR, interquartile range; and WMH, White matter hyperintensities

*P<0.05.

P<0.001.

We found similar changes from wave 1 to 2 for BP taken while sitting or standing; therefore, all subsequent analyses refer to sitting BP (data for standing available on request). There was no significant change in SBP (Table 1), but mean and DBP fell significantly (P<0.001) and thus pulse pressure increased significantly (P<0.001) from wave 1 to 2. The mean absolute WMH volume was 12.05±12.84 mm3 or 0.83±0.90% of intracranial volume. The total median and interquartile range Fazekas score was 2.0±1.0, range 0 to 6.

BP and ICA Blood Velocity Parameters

For brevity, only the summary results of the regression analyses are presented here (Figure; Table 2; Figure S1). Full results, including covariate effects, are reported in Table S3. There were numerous relatively weak associations between BP and ICA velocities, but in general, these were strongest and most consistent for lower DBP and higher ICA pulsatility index (with few associations for SBP) and for BP measured at wave 2 (results in text) than at wave 1 (Table 2). Thus, higher ICA systolic and mean velocities were associated with lower DBP (all P<0.001) and higher pulse pressure (all P<0.004). Higher ICA diastolic velocity was associated with lower DBP (β=−0.09; P=0.024) and lower mean BP (β=−0.08; P=0.029) but no other BP measure. Higher ICA pulsatility index was associated with higher SBP (β=0.08; P=0.04), lower DBP (β=−0.19, P<0.001), and higher pulse pressure (β=0.10; P=0.008). Higher ICA resistivity index was associated with lower DBP (β=−0.18; P<0.001) and higher pulse pressure (β=0.17; P<0.001). All the significant associations remained significant after a correction for false-discovery rate was applied. There were no associations for BP variability parameters (Table S1).

Table 2. Association Between Measures of BP and ICA Blood Velocity Parameters

BP Measures Blood Velocity in the ICA Pulsatility Index Resistivity Index
Systolic Velocity Mean Velocity Diastolic Velocity
Wave 1
 Systolic BP 0.06 (0.141, 0.256) 0.04 (0.285, 0.407) 0.01 (0.76, 0.80) 0.04 (0.335, 0.447) 0.04 (0.256, 0.394)
 Mean BP −0.04 (0.245, 0.394) −0.02 (0.647, 0.711) 0.02 (0.533, 0.627) −0.11 (0.003, 0.009)* −0.08 (0.054, 0.111)
 Diastolic BP −0.13 (0.001,0.003)* −0.07 (0.068,0.120) 0.03 (0.423,0.529) −0.24 (<0.0001, <0.0005)* −0.18 (<0.0001, <0.0005)*
 Pulse pressure 0.15 (<0.0001, <0.0005)* 0.09 (0.011, 0.028)* −0.01 (0.887, 0.88) 0.19 (<0.0001, <0.0005)* 0.17 (<0.0001, <0.0005)*
Wave 2
 Systolic BP 0.02 (0.536, 0.596) −0.01 (0.757, 0.850) −0.06 (0.114, 0.147) 0.11 (0.004, 0.014)* 0.10 (0.013, 0.022)*
 Mean BP −0.10 (0.009, 0.018)* −0.10 (0.008, 0.018)* −0.08 (0.029, 0.031)* −0.04 (0.349, 0.400) −0.01 (0.722, 0.75)
 Diastolic BP −0.20 (<0.0001,<0.0005)* −0.17 (<0.0001, <0.0005)* −0.09 (0.024, 0.029)* −0.18 (<0.0001, <0.005)* −0.12 (0.002, 0.003)*
 Pulse pressure 0.13 (<0.0001, <0.004)* 0.11 (0.004, 0.010)* 0.05 (0.217, 0.271) 0.12 (0.002, 0.007)* 0.10 (0.012, 0.022)*

Values are standardized β (P value, false-discovery rate corrected P values) for the sitting BP measures predicting ICA blood velocity measures after accounting for covariates. See Table S3 for full covariate effects. BP indicates blood pressure; and ICA, internal carotid artery.

*Associations that remained significant after applying a correction for false-discovery rate.

Figure.

Figure. Summary of the associations between measures of blood pressure (BP), of internal carotid artery (ICA) blood velocity parameters, and of white matter hyperintensities (WMH; volume and Fazekas scores). BPs were measured at wave 1 (time point 1), mean age 69.6±0.83 years and wave 2 (time point 2), mean age 72.6±0.71; ICA velocity parameters and WMH were measured at wave 2. Models accounted for all covariates.

BP Measures and WMH Measures

Associations between BP variables and WMH were generally stronger for BP assessed at wave 1 and for Fazekas scores. At wave 1, higher mean BP (β=0.09; P=0.02; Figure; Tables 3 and 4; Figure S1) and DBP (β=0.08; P=0.04) were weakly associated with larger WMH volume, with similar but weaker associations at wave 2. Higher Fazekas scores (Table S4) were significantly associated with higher SBP (wave 1: β=0.12; P=0.002), mean BP (wave 1: β=0.13; P=0.001) and DBP (wave 1: β=0.11; P=0.003), with similar but weaker associations at wave 2. No association was found between WMH measures (WMH volume or Fazekas) and pulse pressure or variability (Table S2). All the significant associations remained significant after correction for false-discovery rate.

Table 3. Association Between White Matter Hyperintensities Volume and Measures of BP (Standardized β [P Value, False-Discovery Rate Corrected P Values])

Measures of BP at Waves 1 or 2 BP Measures Covariates
ICV Sex Age, d
Systolic BP, wave 1 0.08* (0.043,* 0.057) 0.12* (0.021)* 0.08 (0.126) 0.15 (<0.0001)
Systolic BP, wave 2 0.06 (0.113, 0.248) 0.12 (0.019) 0.08 (0.123) 0.14 (<0.0001)
Mean BP, wave 1 0.09* (0.021,* 0.057) 0.11* (0.023)* 0.08 (0.118) 0.15* (<0.0001)*
Mean BP, wave 2 0.06 (0.144, 0.248) 0.12 (0.02) 0.08 (0.131) 0.14 (<0.0001)
Diastolic BP, wave 1 0.08* (0.036,* 0.057) 0.11* (0.025)* 0.08 (0.121) 0.15* (<0.0001)*
Diastolic BP, wave 2 0.04 (0.306, 0.306) 0.12 (0.021) 0.08 (0.123) 0.14 (<0.0001)
Pulse pressure, wave 1 0.04 (0.249, 0.249) 0.12 (0.02) 0.07 (0.142) 0.14 (<0.0001)
Pulse pressure, wave 2 0.05 (0.186, 0.248) 0.12 (0.021) 0.08 (0.131) 0.14 (<0.0001)

Models accounted for all covariates. Dependent variables were measures of white matter hyperintensities, whereas independent variables were measures of internal carotid artery velocities and of BP. Each row represents a separate model which controlled for ICV and demographic variables. Health variables’ inclusion used stepwise method and only those that passed the Akaike Information Criterion test appeared in the final model above. BP indicates blood pressure; and ICV, intracranial volume.

*Indicates associations that were significant.

Table 4. Association Between White Matter Hyperintensities Volume and Measures of ICA Blood Velocity (Standardized β [P Value, False-Discovery Rate Corrected P Values])

Measure of ICA Velocity at Wave 2 ICA Velocity Measures Covariates
ICV Sex Age, d Hypertension
Systolic velocity 0.04 (0.343, 0.428) 0.13 (0.011) 0.09 (0.085) 0.14 (<0.0001) 0.13 (<0.0001)
Mean velocity 0.00 (0.990, 0.990) 0.13 (0.011) 0.09 (0.086) 0.13 (<0.0001) 0.13 (<0.0001)
Diastolic velocity −0.05 (0.178, 0.283) 0.13 (0.012) 0.09 (0.075) 0.13 (0.001) 0.13 (0.001)
Pulsatility index 0.09* (0.016,* 0.08) 0.12 (0.014) 0.10 (0.047) 0.13 (<0.0001) 0.12 (0.002)
Resistivity index 0.07 (0.054, 0.135) 0.12 (0.015) 0.09 (0.066) 0.14 (<0.0001) 0.13 (0.001)

Models accounted for all covariates. Dependent variables were measures of white matter hyperintensities, whereas independent variables were measures of ICA velocities and of blood pressure. Each row represents a separate model which controlled for ICV and demographic variables. Health variables’ inclusion used stepwise method and only those that passed the Akaike Information Criterion test appeared in the final model above. ICA indicates internal carotid artery; and ICV, intracranial volume.

*Indicates associations that were significant.

ICA Blood Velocity Measures and WMH Measures

Without accounting for BP measures (Figure; Tables 3 and 4), larger WMH volume was associated with higher ICA pulsatility index (β=0.09; P=0.016), and higher Fazekas scores (Table S4) were associated with lower ICA diastolic velocity (β=−0.11; P=0.005) and higher resistivity index (β=0.08; P=0.04) but no other ICA blood velocity measures. Accounting for BP measures (Figure; Tables S5 and S7) resulted in marginal adjustments to these associations, larger WMH volume (β=0.13; P=0.002) and higher Fazekas scores (β=0.12; P=0.003) were associated with higher ICA pulsatility index; higher Fazekas scores were also associated with lower ICA diastolic velocity (β=−0.11; P=0.005) and higher resistivity index (β=0.11; P=0.005). The associations between ICA pulsatility and resistivity indices and WMH remained after false-discovery rate correction. No association was found between WMH and other ICA blood velocity measures, but those with history of hypertension had larger WMH volumes (Tables 3 and 4; β=0.13; P<0.001) and higher Fazekas scores (Table S4; β=0.16; P<0.001).

Sensitivity Analyses

The associations among BP, ICA parameters, and WMH were slightly stronger in hypertensive subjects than in normotensive subjects, but there were no differences in direction of association or other features (Table S6). After converting standardized to unstandardized β, for every 1-year increase in age there was approximately a 2.43 cm3 increase in WMH volume. In addition, for every additional individual diagnosis of hypertension, there was ≈3.47 cm3 increase in WMH volume.

Discussion

We investigated associations between BP parameters measured longitudinally, ICA velocity parameters, and WMH in ≈700 community-dwelling individuals aged ≈73 years. Higher SBP, mean BP, and DBP were weakly associated with WMH, especially for BP measured several years previously. Considering the route by which BP effects reach the brain, higher concurrent ICA pulsatility index, largely the result of falling DBP, was associated with WMH (Figure). All associations remained significant after correcting for multiple testing and whether hypertension was included in the model. Thus, the association between BP measures and WMH is different from that between BP measures and WMH when the route between the heart and the brain via the ICAs is accounted for meaning that BP and WMH either associate indirectly through BP elevation earlier in life leading to stiffer vessels which in turn lead to WMH or hypertension and WMH coassociate through advancing age and stiffer vessels. In either case, the data suggest that the route from BP to WMH is indirect in community-dwelling, generally healthy older subjects. Notably, even within this narrow age-range, as little as a 1-year increase in age was associated with 2.43-mL increase in WMH volume, and hypertension (versus no hypertension) was associated with 3.47-mL increase in WMH volume. This novel finding provides important quantitative information on the effect of age and hypertension on WMH.

Comparison With Literature

Our large sample of subjects (694) with longitudinal BP assessments fell within a narrow age-range in their late 60s to early 70s at the 2 waves and were living in the community. The proportion with cardiovascular conditions and risk factors increased for the 3 years, with hypertension increasing from 38% to 50% consistent with previous studies.810,24–28 The association among higher SBP, mean BP, DBP, and WMH is consistent with many previous studies.3,4,8,2932

Some studies9,10 have reported associations between WMH and ICA or MCA pulsatility index, but no previous studies examined associations among BP, ICA parameters, and WMH simultaneously or longitudinally or the role of falling DBP identified in this study. Increased arterial stiffness (measured in various ways, in various arteries) and WMH are emerging: 167 patients with hypertension,12 363 community-dwelling subjects,11 in hypertensive subjects among 1460 community-dwelling subjects,8 in 1587 Framingham subjects,33 in 1800 subjects in the 3C-Dijon Study,34 and in 1270 Dallas Heart Study,35 but none of these studies dissected the complete path from BP via carotid to brain and the subjects’ ages covered several decades. One study of 303 elderly subjects found that pulse wave velocity predicted WMH assessed 10 years later but in only 1 white matter tract (the superior longitudinal fasciculus).36 Lower aortic DBP, increased aortic pulse pressure, and increased MCA pulsatility index were associated with WMH in 100 patients with stroke of wide age-range,10 similar to our findings and suggesting a coassociation rather than a direct association. The powerful effects of age on many biological processes are difficult to correct statistically: in addition to our 2.43-mL/y increase in WMH, MCA flow velocity falls by 0.2 cm/s per year increase in age (P=0.045) and by 3.75 cm/s per point increase in WMH Fazekas score (P=0.004). Consequently, MCA pulsatility index has even been suggested as an office screening tool for WMH.37

We did not find associations of WMH with BP variability although our data were limited for assessing variability, but this is consistent with 2 other large recent prospective studies,31,32 which disagreed with previous cross sectional studies showing BP variability-WMH associations.38,39

BP, ICA Velocities, and Potential Pathophysiological Effects on WMH

In our study, SBP did not change between waves 1 and 2, but DBP fell and consequently pulse pressure increased. Lower DBP, higher pulse pressure and higher ICA pulsatility index, mean and diastolic velocity were consistently associated, but SBP associations were generally inconsistent and weak. After adjusting for BP, larger WMH volume was associated with higher ICA pulsatility index and lower DBP. The pathway from BP to WMH is, therefore, through falling DBP, rising pulse pressure, and ICA pulsatility index. Increased vessel stiffness would fit with emerging evidence that WMH associate more with BP levels taken years earlier than with concurrent readings. Associations between BP and WMH when ICA parameters are not considered, in which SBP is most prominent, are contrary to the direct path of BP transmission to the brain via the carotid arteries where lower DBP is the associated variable. This might suggest that DBP was falling below an acceptable perfusion pressure to result in WMH, but the DBP values (mean, 78.1; SD, 9.68; Table 1) do not suggest that is likely.

Strengths

Strengths include using well-validated image processing tools, accounting for all necessary covariates in the statistical models, and comprehensive assessment of several BP measures at sitting and standing positions, at ages 70 and 73 years; 5 ICA blood velocity measures averaged across right and left and 2 measures of WMH recorded at mean age 73 years. ICA and MCA pulsatility index are closely related; brachial pulse pressure (as measured here) showed the strongest correlation with MCA pulsatility index and explained the largest variance in MCA pulsatility index.5

Limitations

We cannot comment on longitudinal WMH or ICA velocity parameters. The LBC193615,16 participants are currently undergoing repeat MRI to provide longitudinal data. Our variability measures were limited, but other studies with comprehensive longitudinal visit-to-visit variability measures have not found associations.32,40 We did not account for medical treatment, but the risk factor diagnoses and BP measures encompass treatment. Others have shown that BP levels are more important than treatment per se in relation to WMH.31 We calculated mean velocity to avoid errors in machine-calculated values that may have under- or overestimated the time averaged mean; however, pulsatility index (the strongest covariate) is the same whether calculated by hand or machine.

Perspectives

That the association between BP and WMH may be a coassociation acting through increased arterial stiffness has implications for strategies to prevent WMH progression and their cognitive and physical consequences. Treatment of hypertension is important for stroke prevention, but there is less evidence that it reduces WMH progression41,42 (but BP lowering may have been too little or not for long enough) and mixed information about effects on cognition (results of the Secondary Prevention of Small Subcortical Stroke [SPS3] trial on BP lowering in ≥3000 patients with lacunar stroke are awaited). Perhaps therapies to reduce arterial/arteriolar stiffness, by acting more directly on the suggested pathophysiological pathway to WMH, might have valuable effects on preventing WMH progression. Our data suggest that lifestyle or pharmacological methods to reduce arterial stiffness preferentially would be worth evaluating in case some antihypertensive therapies alone are insufficient to restore normal vascular tone and cerebral vasoreactivity.

Conclusions

The association between BP and WMH at older ages, when considering the path via the carotid arteries, is most closely aligned with increased ICA pulsatility index, which was a consequence of falling DBP, questioning the directness of the link between BP and WMH. Longitudinal studies with narrow age-range subjects help to differentiate potentially causal relationships from shared, age-related coassociations. Determining whether it is falling or rising BP in later life that increases risk of WMH, and differential age effects, is important for future prevention of the stroke and dementia consequences of small vessel disease.

Acknowledgments

The imaging was performed in the Brain Research Imaging Centre, University of Edinburgh (http://www.bric.ed.ac.uk), a SINAPSE Centre. The DICOM to Analyze image format conversion tools used in the analysis were written by Dr Armitage.

Footnotes

The online-only Data Supplement is available with this article at http://hyper.ahajournals.org/lookup/suppl/doi:10.1161/HYPERTENSIONAHA.113.02735/-/DC1.

Correspondence to Joanna Wardlaw, Neuroimaging Sciences, University of Edinburgh, Western General Hospital, Bramwell Dott Bldg, Crewe Rd, Edinburgh EH4 2XU, United Kingdom. E-mail

References

  • 1. Wardlaw JM, Smith EE, Biessels GJ, et al . Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration: a united approach.Lancet Neurol. 2013; 12:822–838.CrossrefMedlineGoogle Scholar
  • 2. Debette S, Markus HS . The clinical importance of white matter hyperintensities on brain magnetic resonance imaging: systematic review and meta-analysis.BMJ. 2010; 341:c3666.CrossrefMedlineGoogle Scholar
  • 3. O’Rourke MF, Hashimoto J . Mechanical factors in arterial aging: a clinical perspective.J Am Coll Cardiol. 2007; 50:1–13.CrossrefMedlineGoogle Scholar
  • 4. Shrestha I, Takahashi T, Nomura E, Ohtsuki T, Ohshita T, Ueno H, Kohriyama T, Matsumoto M . Association between central systolic blood pressure, white matter lesions in cerebral MRI and carotid atherosclerosis.Hypertens Res. 2009; 32:869–874.CrossrefMedlineGoogle Scholar
  • 5. Xu TY, Staessen JA, Wei FF, Xu J, Li FH, Fan WX, Gao PJ, Wang JG, Li Y . Blood flow pattern in the middle cerebral artery in relation to indices of arterial stiffness in the systemic circulation.Am J Hypertens. 2012; 25:319–324.CrossrefMedlineGoogle Scholar
  • 6. Benetos A, Waeber B, Izzo J, Mitchell G, Resnick L, Asmar R, Safar M . Influence of age, risk factors, and cardiovascular and renal disease on arterial stiffness: clinical applications.Am J Hypertens. 2002; 15:1101–1108.CrossrefMedlineGoogle Scholar
  • 7. O’Rourke MF, Safar ME . Relationship between aortic stiffening and microvascular disease in brain and kidney: cause and logic of therapy.Hypertension. 2005; 46:200–204.LinkGoogle Scholar
  • 8. Poels MM, Zaccai K, Verwoert GC, Vernooij MW, Hofman A, van der Lugt A, Witteman JC, Breteler MM, Mattace-Raso FU, Ikram MA . Arterial stiffness and cerebral small vessel disease: the Rotterdam Scan Study.Stroke. 2012; 43:2637–2642.LinkGoogle Scholar
  • 9. Mitchell GF, van Buchem MA, Sigurdsson S, Gotal JD, Jonsdottir MK, Kjartansson Ó, Garcia M, Aspelund T, Harris TB, Gudnason V, Launer LJ . Arterial stiffness, pressure and flow pulsatility and brain structure and function: the Age, Gene/Environment Susceptibility–Reykjavik study.Brain. 2011; 134(Pt 11):3398–3407.CrossrefMedlineGoogle Scholar
  • 10. Webb AJ, Simoni M, Mazzucco S, Kuker W, Schulz U, Rothwell PM . Increased cerebral arterial pulsatility in patients with leukoaraiosis: arterial stiffness enhances transmission of aortic pulsatility.Stroke. 2012; 43:2631–2636.LinkGoogle Scholar
  • 11. Hatanaka R, Obara T, Watabe D, et al . Association of arterial stiffness with silent cerebrovascular lesions: the Ohasama study.Cerebrovasc Dis. 2011; 31:329–337.CrossrefMedlineGoogle Scholar
  • 12. Henskens LH, Kroon AA, van Oostenbrugge RJ, Gronenschild EH, Fuss-Lejeune MM, Hofman PA, Lodder J, de Leeuw PW . Increased aortic pulse wave velocity is associated with silent cerebral small-vessel disease in hypertensive patients.Hypertension. 2008; 52:1120–1126.LinkGoogle Scholar
  • 13. Pase MP, Grima NA, Stough CK, Scholey A, Pipingas A . Cardiovascular disease risk and cerebral blood flow velocity.Stroke. 2012; 43:2803–2805.LinkGoogle Scholar
  • 14. Wills AK, Lawlor DA, Matthews FE, Sayer AA, Bakra E, Ben-Shlomo Y, Benzeval M, Brunner E, Cooper R, Kivimaki M, Kuh D, Muniz-Terrera G, Hardy R . Life course trajectories of systolic blood pressure using longitudinal data from eight UK cohorts.PLoS Med. 2011; 8:e1000440.CrossrefMedlineGoogle Scholar
  • 15. Deary IJ, Gow AJ, Taylor MD, Corley J, Brett C, Wilson V, Campbell H, Whalley LJ, Visscher PM, Porteous DJ, Starr JM . The Lothian Birth Cohort 1936: a study to examine influences on cognitive ageing from age 11 to age 70 and beyond.BMC Geriatr.2007; 7:28.CrossrefMedlineGoogle Scholar
  • 16. Wardlaw JM, Bastin ME, Valdés Hernández MC, Maniega SM, Royle NA, Morris Z, Clayden JD, Sandeman EM, Eadie E, Murray C, Starr JM, Deary IJ . Brain aging, cognition in youth and old age and vascular disease in the Lothian Birth Cohort 1936: rationale, design and methodology of the imaging protocol.Int J Stroke. 2011; 6:547–559.CrossrefMedlineGoogle Scholar
  • 17. Howard SC, Rothwell PM . Reproducibility of measures of visit-to-visit variability in blood pressure after transient ischaemic attack or minor stroke.Cerebrovasc Dis. 2009; 28:331–340.CrossrefMedlineGoogle Scholar
  • 18. Muntner P, Joyce C, Levitan EB, Holt E, Shimbo D, Webber LS, Oparil S, Re R, Krousel-Wood M . Reproducibility of visit-to-visit variability of blood pressure measured as part of routine clinical care.J Hypertens.2011; 29:2332–2338.CrossrefMedlineGoogle Scholar
  • 19. Lagro J, Claassen JA, Rikkert MG . Prognostic significance of blood-pressure variability.Lancet. 2010; 376:413–414.CrossrefMedlineGoogle Scholar
  • 20. Alexandrov AV . Section II. Cerebral vessels. In: , Zwiebel WJ, Pellerito JS Introduction to Vascular Ultrasonography. 5th ed. Philadelphia: Elsevier Saunders; 2005:107–131.CrossrefGoogle Scholar
  • 21. Aaslid R, Markwalder TM, Nornes H . Noninvasive transcranial Doppler ultrasound recording of flow velocity in basal cerebral arteries.J Neurosurg.1982; 57:769–774.CrossrefMedlineGoogle Scholar
  • 22. Hernández Mdel C, Ferguson KJ, Chappell FM, Wardlaw JM . New multispectral MRI data fusion technique for white matter lesion segmentation: method and comparison with thresholding in FLAIR images.Eur Radiol.2010; 20:1684–1691.CrossrefMedlineGoogle Scholar
  • 23. Fazekas F, Chawluk JB, Alavi A, Hurtig HI, Zimmerman RA . MR signal abnormalities at 1.5 T in Alzheimer’s dementia and normal aging.AJR Am J Roentgenol. 1987; 149:351–356.CrossrefMedlineGoogle Scholar
  • 24. McDaniel MA . Big-brained people are smarter: a meta-analysis of the relationship between in vivo brain volume and intelligence.Intelligence. 2005; 33:337–346.CrossrefGoogle Scholar
  • 25. Meaume S, Benetos A, Henry OF, Rudnichi A, Safar ME . Aortic pulse wave velocity predicts cardiovascular mortality in subjects >70 years of age.Arterioscler Thromb Vasc Biol. 2001; 21:2046–2050.LinkGoogle Scholar
  • 26. Miura K, Soyama Y, Morikawa Y, Nishijo M, Nakanishi Y, Naruse Y, Yoshita K, Kagamimori S, Nakagawa H . Comparison of four blood pressure indexes for the prediction of 10-year stroke risk in middle-aged and older Asians.Hypertension. 2004; 44:715–720.LinkGoogle Scholar
  • 27. Nair GV, Chaput LA, Vittinghoff E, Herrington DM . Pulse pressure and cardiovascular events in postmenopausal women with coronary heart disease.Chest. 2005; 127:1498–1506.CrossrefMedlineGoogle Scholar
  • 28. Nichols WW, O’Rourke MF Mcdonald’s Blood Flow in Arteries: Theoretical, Experimental and Clinical Principles. London: Hodder Arnold Publication; 1993.Google Scholar
  • 29. Maclullich AM, Ferguson KJ, Reid LM, Deary IJ, Starr JM, Seckl JR, Bastin ME, Wardlaw JM . Higher systolic blood pressure is associated with increased water diffusivity in normal-appearing white matter.Stroke. 2009; 40:3869–3871.LinkGoogle Scholar
  • 30. Waldstein SR, Wendell CR, Lefkowitz DM, Siegel EL, Rosenberger WF, Spencer RJ, Manukyan Z, Katzel LI . Interactive relations of blood pressure and age to subclinical cerebrovascular disease.J Hypertens.2012; 30:2352–2356.CrossrefMedlineGoogle Scholar
  • 31. Verhaaren BF, Vernooij MW, de Boer R, Hofman A, Niessen WJ, van der Lugt A, Ikram MA . High blood pressure and cerebral white matter lesion progression in the general population.Hypertension. 2013; 61:1354–1359.LinkGoogle Scholar
  • 32. Liu W, Liu R, Sun W, Peng Q, Zhang W, Xu E, Cheng Y, Ding M, Li Y, Hong Z, Wu J, Zeng J, Yao C, Huang Y . Different impacts of blood pressure variability on the progression of cerebral microbleeds and white matter lesions.Stroke. 2012; 43:2916–2922.LinkGoogle Scholar
  • 33. Tsao CW, Seshadri S, Beiser AS, Westwood AJ, Decarli C, Au R, Himali JJ, Hamburg NM, Vita JA, Levy D, Larson MG, Benjamin EJ, Wolf PA, Vasan RS, Mitchell GF . Relations of arterial stiffness and endothelial function to brain aging in the community.Neurology. 2013; 81:984–991.CrossrefMedlineGoogle Scholar
  • 34. Brisset M, Boutouyrie P, Pico F, Zhu Y, Zureik M, Schilling S, Dufouil C, Mazoyer B, Laurent S, Tzourio C, Debette S . Large-vessel correlates of cerebral small-vessel disease.Neurology. 2013; 80:662–669.CrossrefMedlineGoogle Scholar
  • 35. King KS, Chen KX, Hulsey KM, McColl RW, Weiner MF, Nakonezny PA, Peshock RM . White matter hyperintensities: use of aortic arch pulse wave velocity to predict volume independent of other cardiovascular risk factors.Radiology. 2013; 267:709–717.CrossrefMedlineGoogle Scholar
  • 36. Rosano C, Watson N, Chang Y, Newman AB, Aizenstein HJ, Du Y, Venkatraman V, Harris TB, Barinas-Mitchell E, Sutton-Tyrrell K . Aortic pulse wave velocity predicts focal white matter hyperintensities in a biracial cohort of older adults.Hypertension. 2013; 61:160–165.LinkGoogle Scholar
  • 37. Mok V, Wong KK, Xiong Y, Wong A, Schmidt R, Chu W, Hu X, Leung EY, Chen S, Chen Y, Tang WK, Chen X, Ho CL, Wong KS, Wong ST . Cortical and frontal atrophy are associated with cognitive impairment in age-related confluent white-matter lesion.J Neurol Neurosurg Psychiatry. 2011; 82:52–57.CrossrefMedlineGoogle Scholar
  • 38. Brickman AM, Reitz C, Luchsinger JA, Manly JJ, Schupf N, Muraskin J, DeCarli C, Brown TR, Mayeux R . Long-term blood pressure fluctuation and cerebrovascular disease in an elderly cohort.Arch Neurol. 2010; 67:564–569.CrossrefMedlineGoogle Scholar
  • 39. Havlik RJ, Foley DJ, Sayer B, Masaki K, White L, Launer LJ . Variability in midlife systolic blood pressure is related to late-life brain white matter lesions: the Honolulu-Asia Aging study.Stroke. 2002; 33:26–30.LinkGoogle Scholar
  • 40. Sabayan B, Wijsman LW, Foster-Dingley JC, Stott DJ, Ford I, Buckley BM, Sattar N, Jukema JW, van Osch MJ, van der Grond J, van Buchem MA, Westendorp RG, de Craen AJ, Mooijaart SP . Association of visit-to-visit variability in blood pressure with cognitive function in old age: prospective cohort study.BMJ. 2013; 347:f4600.CrossrefMedlineGoogle Scholar
  • 41. Dufouil C, Chalmers J, Coskun O, Besancon V, Bousser MG, Guillon P, MacMahon S, Mazoyer B, Neal B, Woodward M, Tzourio-Mazoyer N, Tzourio C . Effects of blood pressure lowering on cerebral white matter hyperintensities in patients with stroke: the PROGRESS (Perindopril Protection Against Recurrent Stroke Study) Magnetic Resonance Imaging Substudy.Circulation. 2005; 112:1644–1650.LinkGoogle Scholar
  • 42. Weber R, Weimar C, Blatchford J, Hermansson K, Wanke I, Möller-Hartmann C, Gizewski ER, Forsting M, Demchuk AM, Sacco RL, Saver JL, Warach S, Diener HC, Diehl A ; PRoFESS Imaging Substudy Group. Telmisartan on top of antihypertensive treatment does not prevent progression of cerebral white matter lesions in the prevention regimen for effectively avoiding second strokes (PRoFESS) MRI substudy.Stroke. 2012; 43:2336–2342.LinkGoogle Scholar

Novelty and Significance

What Is New?

  • Blood pressure (BP) and brain vascular damage seen as white matter hyperintensities (WMH) seem to be linked indirectly through a shared coassociation with increasing arterial stiffness.

  • The complete pathophysiological pathway from BP via internal carotid artery velocity parameters to WMH has not been studied before.

  • Narrow age-range sample allows differentiation of direct from indirect BP effects.

What Is Relevant?

  • Hypertension increases with age and is a major risk factor for WMH.

  • Advancing age strongly influences WMH.

Summary

Increased pulse pressure, secondary to falling diastolic BP, is associated with increased internal carotid artery pulsatility index, which in turn is associated with WMH at the age of 72 years. Further research is required to determine whether methods to reduce arterial stiffness, as well as to reduce BP, prevent WMH formation or progression and their cognitive and physical consequences.

eLetters(0)

eLetters should relate to an article recently published in the journal and are not a forum for providing unpublished data. Comments are reviewed for appropriate use of tone and language. Comments are not peer-reviewed. Acceptable comments are posted to the journal website only. Comments are not published in an issue and are not indexed in PubMed. Comments should be no longer than 500 words and will only be posted online. References are limited to 10. Authors of the article cited in the comment will be invited to reply, as appropriate.

Comments and feedback on AHA/ASA Scientific Statements and Guidelines should be directed to the AHA/ASA Manuscript Oversight Committee via its Correspondence page.